This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shantz, L. M. Articles by Pegg, A. E. Search for Related Content PubMed Articles by Shantz, L. M. Articles by Pegg, A. E.

Ornithine Decarboxylase Induction in Transformation by H-Ras and RhoA¹

Departments of Cellular and Molecular Physiology [L. M. S., A. E. P.] and Pharmacology [A. E. P.], The Milton S. Hershey Medical Center, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033

The objective of these studies has been to develop a better understanding of the regulation of ornithine decarboxylase (ODC) during the neoplastic process, and to determine whether induction of ODC is a necessary component in the action of the ras oncogene. Specifically, we have studied the role of ODC overexpression in signaling pathways mediated by Raf or RhoA. Cells transformed by ras are known to have constitutively high levels of ODC activity that correlate with oncogenic transformation. To determine which pathways downstream of Ras contribute to the regulation of ODC activity, NIH-3T3 cells were transfected with plasmids coding for activated mutants of either H-Ras or RhoA, or oncogenic v-Raf. There was a good correlation between increasing ODC specific activity and change in morphology from normal to transformed in the v-Raf, HRas(61L), and RhoA(63L) clones. Increasing ODC activity also correlated positively with the ability to grow in soft agar in both the H-Ras- and RhoA-expressing cells. In stable transfections, coexpression of the ODC dominant negative mutant K69A/C360A with either HRas(61L) or RhoA(63L) both inhibited intracellular ODC activity and caused a reversion of the transformed phenotype, as measured by a dramatic reduction in the ability of these cells to grow in soft agar and form foci on a monolayer. These results suggest strongly that ODC induction is necessary for transformation by oncogenic Ras. In contrast, expression of K69A/C360A had no effect on the ability of v-Raf-transformed cells to grow in soft agar, although intracellular ODC levels were inhibited. When grown on a monolayer, these cells also maintained their transformed appearance. Furthermore, expression of the ODC dominant negative mutant did not affect the phosphorylation of mitogen-activated protein kinase in v-Raf-transformed cells. These experiments provide strong support for the concept that transformation by activated ras is accompanied by an induction of ODC. The results using RhoA(63L) and v-Raf suggest that this increase in ODC activity is mediated at least in part through a Raf/mitogen-activated protein kinase independent pathway.

¹ Supported by Grant IRG-196A from the American Cancer Society (to L. M. S.), the Pennsylvania State University Four Diamonds Fund (to L. M. S.), and Grant CA-18138 from the National Cancer Institute (to A. E. P.).

² To whom requests for reprints should be addressed, at Department of Cellular and Molecular Physiology, The Milton S. Hershey Medical Center, The Pennsylvania State University College of Medicine, 500 University Drive, H166, Hershey, PA 17033.

Received 12/30/97. Accepted 4/30/98.

This article has been cited by other articles:

				S. Origanti and L. M. Shantz Ras Transformation of RIE-1 Cells Activates Cap-Independent Translation of Ornithine Decarboxylase: Regulation by the Raf/MEK/ERK and Phosphatidylinositol 3-Kinase Pathways Cancer Res., May 15, 2007; 67(10): 4834 - 4842. [Abstract] [Full Text] [PDF]

				D. J. Feith, S. Origanti, P. L. Shoop, S. Sass-Kuhn, and L. M. Shantz Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis Carcinogenesis, May 1, 2006; 27(5): 1090 - 1098. [Abstract] [Full Text] [PDF]

				A. A. Adjei and M. Hidalgo Intracellular Signal Transduction Pathway Proteins As Targets for Cancer Therapy J. Clin. Oncol., August 10, 2005; 23(23): 5386 - 5403. [Abstract] [Full Text] [PDF]

				D. J. Feith, D. K. Bol, J. M. Carboni, M. J. Lynch, S. Sass-Kuhn, P. L. Shoop, and L. M. Shantz Induction of Ornithine Decarboxylase Activity Is a Necessary Step for Mitogen-Activated Protein Kinase Kinase-Induced Skin Tumorigenesis Cancer Res., January 15, 2005; 65(2): 572 - 578. [Abstract] [Full Text] [PDF]

				V. A. Levin, J. L. Jochec, L. M. Shantz, P. E. Koch, and A. E. Pegg Tissue-based Assay for Ornithine Decarboxylase to Identify Patients Likely to Respond to Difluoromethylornithine J. Histochem. Cytochem., November 1, 2004; 52(11): 1467 - 1474. [Abstract] [Full Text] [PDF]

				M. Kielosto, P. Nummela, R. Katainen, V. Leaner, M. J. Birrer, and E. Holtta Reversible Regulation of the Transformed Phenotype of Ornithine Decarboxylase- and Ras-Overexpressing Cells by Dominant-Negative Mutants of c-Jun Cancer Res., June 1, 2004; 64(11): 3772 - 3779. [Abstract] [Full Text] [PDF]

				L. Y. Y. Fong, D. J. Feith, and A. E. Pegg Antizyme Overexpression in Transgenic Mice Reduces Cell Proliferation, Increases Apoptosis, and Reduces N-Nitrosomethylbenzylamine-induced Forestomach Carcinogenesis Cancer Res., July 15, 2003; 63(14): 3945 - 3954. [Abstract] [Full Text] [PDF]

				R. G. Schipper and A. A.J. Verhofstad Distribution Patterns of Ornithine Decarboxylase in Cells and Tissues: Facts, Problems, and Postulates J. Histochem. Cytochem., September 1, 2002; 50(9): 1143 - 1160. [Abstract] [Full Text] [PDF]

				L. M. Shantz, Y. Guo, J. A. Sawicki, A. E. Pegg, and T. G. O'Brien Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation Carcinogenesis, April 1, 2002; 23(4): 657 - 664. [Abstract] [Full Text] [PDF]

				D. J. Feith, L. M. Shantz, and A. E. Pegg Targeted Antizyme Expression in the Skin of Transgenic Mice Reduces Tumor Promoter Induction of Ornithine Decarboxylase and Decreases Sensitivity to Chemical Carcinogenesis Cancer Res., August 1, 2001; 61(16): 6073 - 6081. [Abstract] [Full Text] [PDF]

				S. Carnesecchi, Y. Schneider, J. Ceraline, B. Duranton, F. Gosse, N. Seiler, and F. Raul Geraniol, a Component of Plant Essential Oils, Inhibits Growth and Polyamine Biosynthesis in Human Colon Cancer Cells J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 197 - 200. [Abstract] [Full Text]

				L. Lan, C. Trempus, and S. K. Gilmour Inhibition of Ornithine Decarboxylase (ODC) Decreases Tumor Vascularization and Reverses Spontaneous Tumors in ODC/Ras Transgenic Mice Cancer Res., October 1, 2000; 60(20): 5696 - 5703. [Abstract] [Full Text]

				S. Gupta, N. Ahmad, S. R. Marengo, G. T. MacLennan, N. M. Greenberg, and H. Mukhtar Chemoprevention of Prostate Carcinogenesis by {{alpha}}-Difluoromethylornithine in TRAMP Mice Cancer Res., September 1, 2000; 60(18): 5125 - 5133. [Abstract] [Full Text]

				R. G. Schipper, N. Romain, A. A. Otten, J. Tan, W. P. Lange, and A. A. J. Verhofstad Immunocytochemical Detection of Ornithine Decarboxylase J. Histochem. Cytochem., November 1, 1999; 47(11): 1395 - 1404. [Abstract] [Full Text]

				Y. Wang, W. Devereux, T. M. Stewart, and R. A. Casero Jr. Cloning and Characterization of Human Polyamine-modulated Factor-1, a Transcriptional Cofactor That Regulates the Transcription of the Spermidine/Spermine N1-Acetyltransferase Gene J. Biol. Chem., July 30, 1999; 274(31): 22095 - 22101. [Abstract] [Full Text] [PDF]